FDA WARNING_LETTER - Vape Dojo Corporate Headquarters - December 15, 2023

FDA WARNING_LETTER for Vape Dojo Corporate Headquarters on December 15, 2023. Product: Tobacco. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for Vape Dojo Corporate Headquarters on December 15, 2023. Product: Tobacco. Access full analysis and detailed observations.

Violation Codes

21 U.S.C. 387b(6)(A)

21 U.S.C. 387j(a)

21 CFR 1143

21 CFR 1100.1

21 U.S.C. 387a(b)

21 U.S.C. 387e(j)(3)

21 U.S.C. 387e(j)

21 U.S.C. 387j(c)(1)(A)(i)

21 U.S.C. 321(rr)

FD&C Act 902

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Vape Dojo Corporate Headquarters

Inspection Date

December 15, 2023

Product Type

Tobacco

Office

Center for Tobacco Products

People

Jill Atencio (Acting Director)

ID: b8765d1d-7cff-4124-8ae7-49ece1a31ae9

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox